DVI Health Services of Irvine, CA, switched its stock listingfrom the NASDAQ over-the-counter market to the New York StockExchange last week. At the same time, DVI offered 1.525 millionshares of common stock in New York at $10 per share. The
DVI Health Services of Irvine, CA, switched its stock listingfrom the NASDAQ over-the-counter market to the New York StockExchange last week. At the same time, DVI offered 1.525 millionshares of common stock in New York at $10 per share. The companytrades on the NYSE under the symbol "DVI."
DVI was formed in 1985 and listed initially on NASDAQ in August1990, according to the firms' prospectus for the recent stockoffering. Funds raised from the offering will help DVI build itsimaging center business.
Until a year ago, DVI was strictly a lessor of medical imagingand therapeutic equipment nationwide (see charts). The firm branchedinto ownership of freestanding imaging centers last year followingfederal and state moves to restrict referring-physician ownershipof medical centers to which they refer patients, according tothe prospectus.
Two subsidiary companies were formed to operate the new servicebusinesses:
DVI has acquired interests in two existing outpatient facilitiesand developed six centers that are now in operation. The firmis improving an additional outpatient center. All but one center,which provides renal lithotripsy services, involve diagnosticimaging services, the prospectus said.
Equipment financing remains the largest business for DVI, althoughthe firm expects clinical operations and support services to becomeincreasingly important.
The leasing business has been good over the last 18 months.Scanner vendors have offered volume discounts, and interest ratesfor acquisition of the equipment have dropped more than DVI'sleasing charges, the prospectus said.
Revenues rose 55% for DVI during its third quarter (end-March),from $5.4 million in 1991 to $8.4 million this year. Net earningsrose 52% from $471,000 in the third quarter of 1991 to $714,000in the same period of 1992 (see graph).
DVI intends to provide equipment to its centers through thesame lease arrangements used in its existing financing business,the firm said.
The company has also recently moved into the provision of fee-per-scanservices (SCAN 5/6/92). DVI does not expect this type of financingto become a material part of its business, however.
According to DVI, two major risks of the imaging services businessare:
"Because of growing national concern with rising health-carecosts and improvements in the use of costly medical equipmentsuch as MRI systems, the amount that government and other third-partypayers reimburse for individual outpatient health-care procedures,including diagnostic imaging, is likely to be reduced," DVIsaid in its prospectus.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.